Cancer Clinical Trials Results

Cancer Answer Line: 866.223.8100

Cancer Answer Line:

866.223.8100

Cancer Clinical Trials Results

IRBCCTitleHospitalStagePhaseDisease
RTOG 0534CC657Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA After Radical ProstatectomyFairview, Hillcrest, Independence, Main Campus, North Coast Cancer, Strongsville, Wooster Phase 3Prostate
RTOG 0538CC707Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and EtoposideFairview, Hillcrest, Independence, Main Campus, North Coast Cancer, Strongsville, Wooster Phase 3Lung
RTOG 0631CC834Phase II/III Study of Image Guided Radiosurgery / SBRT for Localized Spine MetastasisMain Campus Phase 2, Phase 3Spine
RTOG 0834CC945Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.Main Campus Phase 3Brain
RTOG 0839CC00137Randomized Phase II Study of Pre-Operative Chemoradiotherapy +/- Panitumumab (IND #110152) Followed By Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIA, N2+) Non-Small Cell Lung CancerMain Campus, StrongsvilleStage 3APhase 2Lung
RTOG 0912CC00120A Randomized Phase II Study of Concurrent Intensity Modulated Radiation Therapy (IMRT), Paclitaxel and Pazopanib (NSC 737754)/Placebo, For the Treatment of Anaplastic Thyroid CancerMain Campus Phase 2Head & Neck, Thyroid
RTOG 0920CC825A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck CancerBeachwood, Fairview, Hillcrest, Independence, Main Campus, North Coast Cancer, Wooster  Head & Neck
RTOG 0924CC11-033Androgen deprivation therapy and high dose radiotherapy with or without whole-pelvic radiotherapy in unfavorable intermediate or favorable high risk prostate cancer: a phase III randomized trialFlorida WestonStage 1C, Stage 2, Stage 2A, Stage 2B, Stage 2C, Stage 3, Stage 3A, Stage 3B, Stage 3C, Stage 4Phase 3Prostate
RTOG 0937CC916Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)Fairview, Hillcrest, Independence, Main Campus, North Coast Cancer, Strongsville, Wooster Phase 2Lung
RTOG 1008CC00031A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High - Risk Malignant Salivary Gland TumorsMain Campus Phase 2Head & Neck
RTOG 1016CC00181Phase III Trial of Radiotherapy Plus Cetuximab versus Chemoradiotherapy in HPV-Associated Oropharynx CancerFairview, Hillcrest, Independence, Main Campus, North Coast Cancer, Parma, Wooster Phase 3Head & Neck
RTOG 1106081201CRandomized Phase II Trial of Individualized Adaptive Radiotherapy Using During-Treatment FDG-PET/CT and Modern Technology in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Main Campus  Lung
RTOG 111412-583A Phase II Randomized Study of Rituximab, Methotrexate, Vincristine and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System LymphomaMain Campus Phase 2Brain
RTOG 111913-551Phase II Randomized study of whole brain radiotherapy in combination with concurrent lapatinib in patients with brain metastasis from HER2-Positive Breast cancer. A collaborative study of RTOG and KROG.Beachwood, Fairview, Hillcrest, Independence, North Coast Cancer, Parma, Strongsville, Wooster Phase 2Brain, Breast
RTOG 121613-420Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin versus Docetaxel versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and NeckFairview, Hillcrest, Independence, North Coast Cancer, Parma, Strongsville, Wooster Phase 2Head & Neck
RTOG 122114-225RANDOMIZED PHASE II TRIAL OF TRANSORAL ENDOSCOPIC HEAD AND NECK SURGERY FOLLOWED BY RISK-BASED IMRT AND WEEKLY CISPLATIN VERSUS IMRT AND WEEKLY CISPLATIN FOR HPV NEGATIVE OROPHARYNX CANCERMain Campus Phase 2Head & Neck
RTOG 130614-577A Randomized Phase II Study Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung CancerBeachwood, Fairview, Hillcrest, Independence, Main Campus, North Coast Cancer, Strongsville, Wooster Phase 2Lung, NSCLC (Non-small cell lung cancer)
RTOG 3501121202CA Phase II, Randomized, Double Blind, Placebo-Controlled study of Lapatinib (TYKERB) for Non-HPV Locally Advanced Head and Neck Cancer wtih Concurrent ChemoRadiationMain Campus Phase 2Head & Neck
RTOG092513-474Natural History of Postoperative Cognitive Function, Quality of Life, and Seizure Control in Patients with Supratentorial Low-Risk Grade II GliomaMain Campus  Brain

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).

Referrals

Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.

This information is provided by Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition.

© Copyright 2014 Cleveland Clinic. All rights reserved.

Cleveland Clinic Mobile Site